Study under review: A randomized controlled trial contrasting the effects of 4 low-calorie sweeteners and sucrose on body weight in adults with overweight or obesity.
Overweight and obesity raise the risk of numerous health conditions, including type 2 diabetes, cancer, and cardiovascular disease, and pose a severe financial burden to the healthcare system. As an excessive energy intake is a fundamental cause of overweight and obesity, changes in dietary habits are a cornerstone of bodyweight control.
One recommended dietary modification to help manage bodyweight is the reduction of added sugar consumption. The main rationale for this recommendation is that added sugars, especially in liquid form (i.e. as commonly found in sodas, fruit juices, sports drinks, and energy drinks), contribute calories without suppressing appetite, thereby contributing to weight gain by promoting a positive energy balance.
A common strategy to help reduce sugar intake is to replace sugary drinks with drinks that are sweetened with low-calorie sweeteners (LCSs). These substances have a sweetening potency several hundred times greater than that of sucrose, and can, therefore, deliver sweetness with minimal or no associated energy. Some of the more common LCSs, along with their brand names and their relative sweetness compared to sugar, are shown in Figure 1. However, while some research suggests that using LCSs in place of sugar may lead to reduced bodyweight, other research has reported neutral effects.
One reason for the inconsistent experimental research results could be that different LCSs may differentially affect appetite, brain reward activation, the gut microbiome, and metabolism. However, before investigating the mechanisms by which different LCSs may differentially affect bodyweight, it should first be established that they do, in fact, lead to differential outcomes in bodyweight when chronically consumed.
The study under review aimed to investigate whether LCSs affect bodyweight differently by evaluating the effects of the consumption of four commonly consumed LCSs: aspartame, saccharin, rebaudioside A (often simply referred to as ‘stevia’), and sucralose, as well as sucrose on bodyweight, body composition, energy intake and expenditure, appetite, and glycemia over a 12-week period in adults with overweight or obesity.
A common dietary strategy to help manage bodyweight is the replacement of sugary drinks with drinks that are sweetened with low-calorie sweeteners (LCSs). However, the research investigating the effects of LCSs on bodyweight has found mixed results, which may be partly due to the unique chemical structure of each LCS. To establish whether different LCSs differentially affect bodyweight, the study under review examined the effects of four LCSs (aspartame, saccharin, rebaudioside A, and sucralose) and sucrose on bodyweight, body composition, energy intake and expenditure, appetite, and glycemia in adults with overweight or obesity.
Other Articles in Issue #58 (August 2019)
Eating early in the day keeps glucose spikes at bay
In addition to helping with glycemic control, early time-restricted feeding may affect the expression of certain genes related to circadian rhythms and longevity, too.
Causally or corollary? An innovatively random approach to the TMAO question
Some research has supported the idea that trimethylamine N-oxide (TMAO, a metabolite of compounds found in animal products) is as scary as it sounds. But that research was mostly observational. This study investigated whether TMAO's link to metabolic disease is causal.
Under pressure: reducing salt intake to lower blood pressure
Does reducing salt intake actually reduce blood pressure? If so, by how much? This meta-analysis aimed to answer these questions.
Your brain on ketones: Does a ketogenic diet affect cognition, sleep, and mood?
Ketogenic diets affect nerves; that's why they're an effective treatment for some seizure disorders. But how these diets affect mood and cognition is less clear.
Interview: Lisa Lewis, EdD, CADC-II
In this interview with sports psychologist Lisa Lewis, we chat about some key takeaways from the field of sports psychology, behavioral addiction in sports, and more.
Mini: WHO guidelines for reducing the risk of cognitive decline and dementia
There's no cure for dementia, but there are some clear modifiable risk factors. Here, we summarize the first-ever World Health Organization guidelines for reducing the risk of cognitive decline and dementia.
Can some blueberries each day keep the doctor away?
How do freeze-dried blueberries affect the cardiometabolic health of people with the metabolic syndrome? This study aimed to find out.